NLS Pharmaceutics AG
NASDAQ:NLSP

Watchlist Manager
NLS Pharmaceutics AG Logo
NLS Pharmaceutics AG
NASDAQ:NLSP
Watchlist
Price: 0.164 USD 9.77% Market Closed
Updated: May 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.3m
-76%
Assets
Growth Rates:
1 Year
+10%
3 Years
+255%
5 Years
-
7 Years
-
10 Years
-
6.6m
+9%
Liabilities
Growth Rates:
1 Year
+7%
3 Years
-18%
5 Years
-
7 Years
-
10 Years
-
-4.3m
Equity
Growth Rates:
1 Year
-6%
3 Years
+42%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
NLS Pharmaceutics AG

2.3m
Assets
6.6m
Liabilities
2.3m
Assets
6.6m
Liabilities
Current Assets 2.2m
Cash & Short-Term Investments 1.7m
Receivables 64.3k
Other Current Assets 529.5k
Non-Current Assets 25k
PP&E 12.4k
Other Non-Current Assets 12.6k
Current Liabilities 3.9m
Accounts Payable 3.1m
Accrued Liabilities 779.4k
Other Current Liabilities -10
Non-Current Liabilities 2.7m
Other Non-Current Liabilities 2.7m

Balance Sheet
NLS Pharmaceutics AG

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
2
0
0
0
5
9
Cash Equivalents
2
0
0
0
5
9
Total Receivables
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
0
Total Current Assets
2
0
0
0
6
9
PP&E Net
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Note Receivable
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
1
0
0
Total Assets
2
N/A
0
-93%
1
+367%
1
+73%
6
+376%
9
+61%
Liabilities
Accounts Payable
1
1
3
4
2
2
Accrued Liabilities
0
1
1
1
1
1
Short-Term Debt
0
1
1
1
0
0
Current Portion of Long-Term Debt
0
0
0
1
0
0
Total Current Liabilities
1
2
4
7
2
3
Long-Term Debt
9
6
0
0
0
0
Other Liabilities
0
0
3
3
3
3
Total Liabilities
10
N/A
9
-10%
7
-23%
10
+48%
5
-49%
6
+15%
Equity
Common Stock
0
0
0
0
0
1
Retained Earnings
16
21
27
30
42
58
Additional Paid In Capital
8
13
21
21
42
61
Treasury Stock
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
Total Equity
8
N/A
9
-14%
6
+30%
9
-46%
1
N/A
3
+507%
Total Liabilities & Equity
2
N/A
0
-93%
1
+367%
1
+73%
6
+376%
9
+61%
Shares Outstanding
Common Shares Outstanding
12
12
12
12
16
32

See Also

Summary
NLSP intrinsic value, competitors valuation, and company profile.
DCF Valuation
NLSP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NLSP stock valuation using valuation multiples.
Wall Street Estimates
NLSP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NLSP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.